DOD Research Grants Face Uncertain Future

WASHINGTON—A Defense Department program that distributed $124 million last year in contracts to university researchers appears to have been a one-time windfall for academic scientists. Its survival, which is uncertain given the pressure to trim military spending and reduce the federal deficit, could hurt other researchers funded by the Pentagon. The University Research Initiative (URI) was created as a way to provide universities with money for equipment, training and research in areas fel

Written byDan Charles
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The University Research Initiative (URI) was created as a way to provide universities with money for equipment, training and research in areas felt to have military value. Congress, in a burst of enthusiasm for basic research, added $75 million to the Pentagon's initial $25 million program request. Cuts mandated by the GrammRudman law pared the 1986 appropriation to $90 million, and Congress approved only $34 million for the program in 1987 because the 1986 money was not released until the end of the fiscal year.

Funding for the program was expected to grow each year, supporting a stream of new, multi-year awards. But the high initial level of funding, although it gave the program a flying start, made it unlikely that new awards would be made until the initial grants expired.

Continuing annual appropriations of $90 million to $100 million are needed to fund the multi-year URI contracts at current ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies